Ohio vs Pennsylvania Cannabis Laws

Ohio became the 24th state to legalize recreational cannabis when voters approved Issue 2 in November 2023. As the seventh most populous state with 11.8 million residents, Ohio immediately became one of the most important cannabis markets in the country. Recreational sales launched in August 2024 through existing medical dispensaries, providing a relatively smooth transition from the medical program established in 2016.

The Ohio market's scale is significant. The medical program had already served over 300,000 registered patients, demonstrating strong demand even under medical-only access. With recreational legalization, the addressable market has expanded dramatically. Ohio's 10% excise tax rate is moderate and positions the legal market competitively. The state's central location in the Midwest, surrounded by states with less permissive cannabis laws (Indiana, Kentucky, West Virginia), drives additional cross-border demand.

Ohio is a priority market for all major MSOs. Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, Verano, TerrAscend, and Ayr Wellness all hold licenses in the state. The large population, strong existing medical infrastructure, and limited competition from neighboring states make Ohio one of the most anticipated growth markets in the US cannabis industry.

Pennsylvania is the second-largest medical-only cannabis market in the United States, trailing only Florida. The state's Medical Marijuana Act was signed in April 2016, and dispensaries began serving patients in 2018. The market has grown to approximately $2 billion in annual sales, supported by a patient registry that has grown to over 400,000 active cardholders.

The Pennsylvania market operates under a limited license structure with vertically integrated grower/processor permits and separately issued dispensary licenses. The state has issued a limited number of each, making Pennsylvania licenses among the most valuable in the industry. Governor Josh Shapiro has publicly supported recreational legalization, and legislative efforts continue, making Pennsylvania one of the most watched states for potential recreational conversion.

Pennsylvania is a critical market for nearly every major MSO. Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, Verano, TerrAscend, and Ayr Wellness all hold licenses in the state. If recreational legalization passes, the market could potentially double or triple in size given the state's 13 million population. The current 5% gross receipts tax on grower/processors is relatively modest, with no additional patient-facing cannabis tax beyond standard considerations. Pennsylvania's potential recreational conversion is one of the most significant catalysts for the cannabis industry.